Braskem (BAK)
(Delayed Data from NYSE)
$7.27 USD
+0.36 (5.21%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $7.29 +0.02 (0.28%) 5:06 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.27 USD
+0.36 (5.21%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $7.29 +0.02 (0.28%) 5:06 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Wall Street Analysts Predict a 46.24% Upside in Braskem (BAK): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 46.2% in Braskem (BAK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Should Value Investors Buy Braskem (BAK) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Braskem (BAK) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Braskem (BAK) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
New Strong Sell Stocks for November 10th
by Zacks Equity Research
MT, BAK and CSL have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2023.
Petrobras (PBR) Requests Access to Braskem's Due Diligence Data
by Zacks Equity Research
Petrobras (PBR) seeks access to Braskem's due diligence information for preemptive rights to sell shares held by controlling shareholder Novonor.
Petrobras (PBR) Shows Reluctance Over Acquiring Braskem
by Zacks Equity Research
Petrobras (PBR) expresses unwillingness in exercising its right to acquire Braskem and consolidate the latter's debt.
New Strong Sell Stocks for July 28th
by Zacks Equity Research
ACER, BAK, and CJPRY have been added to the Zacks Rank #5 (Strong Sell) List on July 28, 2022.
Are Investors Undervaluing Braskem (BAK) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Braskem (BAK) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Braskem (BAK) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will High Costs & Low Sales Dent Braskem (BAK) Q1 Earnings?
by Zacks Equity Research
Braskem's (BAK) upward cost trajectory is likely to have continued in the first quarter due to higher feedstock prices in international markets and global supply chain constraints.
E vs. BAK: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
E vs. BAK: Which Stock Is the Better Value Option?
Best Growth Stocks to Buy for April 1st
by Zacks Equity Research
BAK, VLO, and MXL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 1, 2022.
Best Income Stocks to Buy for March 14th
by Zacks Equity Research
BAK, IBCP, and AUB made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 14, 2022.
Best Growth Stocks to Buy for March 14th
by Zacks Equity Research
ABG, COP, and BAK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 14, 2022.
Best Growth Stocks to Buy for March 11th
by Zacks Equity Research
ABG, ARCB, and BAK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 11, 2022.
Best Income Stocks to Buy for March 8th
by Zacks Equity Research
HMN, BAK, and LCNB made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 8, 2022.
New Strong Buy Stocks for March 8th
by Zacks Equity Research
TMST, TSE, HCC, BAK, and CNXC have been added to the Zacks Rank #1 (Strong Buy) List on March 8, 2022.
Best Growth Stocks to Buy for February 25th
by Zacks Equity Research
ABG, ARCB, and BAK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 25, 2022
Best Growth Stocks to Buy for February 24th
by Zacks Equity Research
ABG, ARCB, and BAK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 24, 2022
What Makes Braskem (BAK) a New Strong Buy Stock
by Zacks Equity Research
Braskem (BAK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Does Braskem (BAK) Have the Potential to Rally 30% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 30.3% upside potential for Braskem (BAK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Best Momentum Stocks to Buy for February 23rd
by Zacks Equity Research
TS, BAK, and IRT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 23, 2022
Best Income Stocks to Buy for February 23rd
by Zacks Equity Research
GOGL, BA, and TS made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 23, 2022
New Strong Buy Stocks for February 23rd
by Zacks Equity Research
AMN, AN, BAK, CBOE, and TPH have been added to the Zacks Rank #1 (Strong Buy) List on February 23, 2022.